Skip to content

ACET

Adicet Bio, Inc.

NASDAQ · Healthcare · Biotechnology · US

$9.18
+1.89%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 7, 2026Klickstein Lloyd · director, officer: Chief Medical OfficerA-Award18,300$9.16
Jun 23, 2026Grissinger Michael · directorA-Award4,200$8.10
Jun 23, 2026Sinclair Andrew · directorA-Award4,200$8.10
Jun 23, 2026Peng Katie · directorA-Award4,200$8.10
Jun 23, 2026Chodakewitz Jeffrey · directorA-Award4,200$8.10
Jun 23, 2026Schor Chen · director, officer: President & CEOA-Award55,000$8.10
Jun 23, 2026DUBIN STEVE · directorA-Award4,200$8.10
Jun 23, 2026Aftab Blake · officer: Chief Scientific OfficerA-Award55,000$8.10
Jun 23, 2026Klickstein Lloyd · directorA-Award4,200$8.10
Apr 13, 2026RA CAPITAL MANAGEMENT, L.P. · 10 percent ownerPurchase74,577$7.04
Apr 13, 2026RA CAPITAL MANAGEMENT, L.P. · 10 percent ownerPurchase74,751$7.27
Apr 13, 2026RA CAPITAL MANAGEMENT, L.P. · 10 percent ownerPurchase74,268$7.21
Apr 9, 2026ORBIMED ADVISORS LLC · 10 percent ownerSale40,416$6.52
Apr 9, 2026ORBIMED ADVISORS LLC · 10 percent ownerSale32,523$6.29
Apr 9, 2026ORBIMED ADVISORS LLC · 10 percent ownerSale29,319$6.53
Apr 9, 2026ORBIMED ADVISORS LLC · 10 percent ownerSale2,400$6.38
Mar 27, 2026Healey Don · officer: Chief Technology OfficerA-Award43,361$6.81
Mar 27, 2026Schor Chen · director, officer: President & CEOA-Award468,555$6.81
Mar 27, 2026Maltzman Julia D. · officer: Chief Medical OfficerA-Award72,555$6.81
Mar 27, 2026Aftab Blake · officer: Chief Scientific OfficerA-Award72,555$6.81
Mar 27, 2026Harvey Brian Nicholas · officer: Chief Financial OfficerA-Award43,361$6.81
Jan 27, 2026Schor Chen · director, officer: President & CEOF-InKind1,755$8.44
Jan 27, 2026Healey Don · officer: Chief Technology OfficerF-InKind535$8.44
Jan 27, 2026Aftab Blake · officer: Chief Scientific OfficerF-InKind535$8.44
Jan 27, 2026Harvey Brian Nicholas · officer: Chief Financial OfficerF-InKind546$8.44
Oct 10, 2025ORBIMED ADVISORS LLC · 10 percent ownerPurchase3,500,000$1.00
Oct 10, 2025ORBIMED ADVISORS LLC · 10 percent ownerPurchase1,500,000$1.00
Jun 13, 2025Sinclair Andrew · directorA-Award26,400$0.78
Jun 13, 2025Peng Katie · directorA-Award5,900$0.00
Jun 13, 2025Peng Katie · directorA-Award26,400$0.78
Institutional positioning

13F filings over the trailing two quarters

New 27Increased 29Reduced 20Sold out 7
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Increased1,182,624May 15, 2026
ORBIMED ADVISORS LLCUnchanged1,027,944May 15, 2026
RA CAPITAL MANAGEMENT, L.P.Reduced932,624Aug 14, 2026
ORBIMED ADVISORS LLCReduced844,787Aug 14, 2026
FRANKLIN RESOURCES INCUnchanged626,571Aug 13, 2026
FRANKLIN RESOURCES INCUnchanged626,571May 13, 2026
CITADEL ADVISORS LLCIncreased466,248Sep 2, 2026
CITADEL ADVISORS LLCIncreased381,823May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased343,228Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position336,524May 15, 2026
WOODLINE PARTNERS LPReduced313,124May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged274,375May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged274,375Aug 14, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased265,945Aug 13, 2026
PROSIGHT MANAGEMENT, LPUnchanged250,244May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026